Scott Curley Email & Phone Number | 25+ years of international pharmaceutical experience with Gilead, Amarin, AstraZeneca, and GlaxoSmithKline Currently Head of Commercial Operations for Gilead Canada Prior to this role as GM UK & Ireland for Amarin, oversaw 15M P&L for anticipated 300M PYS primary asset Built Amarin’s UK & Ireland organisation: in Year 1, set new UK CVD market access launch benchmark and established 14 NHS collaborations Developed and led deployment of AstraZeneca’s Enterprise selling model, launch success framework and strategic planning process; received CEO award for transforming market performance during time as GM of Hong Kong Experience in oncology, cardiometabolic, neurology, CNS, respiratory and gastroenterology areas

Scott Curley

25+ years of international pharmaceutical experience with Gilead, Amarin, AstraZeneca, and GlaxoSmit...
Canada

*50 free lookup(s) per month.

Scott Curley’s Phone Numbers +1 908-719-****

Get SCOTT’s Phone Number (For Free)

Social Media

Scott Curley’s Location Canada

Scott Curley’s Current Industry Gilead Sciences

Find accurate emails & phone numbers for over 700M professionals.

Head Of Commercial Operations

2024-01-01 00:00:00 - Present

General Manager – UK & Ireland

2022-07-01 00:00:00 - 2024-01-01 00:00:00

Head of Global & US Commercial Excellence - Biopharmaceuticals

2019-07-01 00:00:00 - 2022-07-01 00:00:00

Company President & General Manager Hong Kong & Macau

2015-02-01 00:00:00 - 2017-10-01 00:00:00

Board Member

2016-04-01 00:00:00 - 2017-10-01 00:00:00

Global Lead, Sales Force Excellence – Specialist Products (Asia Pacific, Japan, Emerging Markets)

2009-06-01 00:00:00 - 2011-06-01 00:00:00

Area Sales Manager - CNS & Diabetes

1999-09-01 00:00:00 - 2002-01-01 00:00:00

No Skills Available

No Languages Available

Scott Curley is a 25+ years of international pharmaceutical experience with Gilead, Amarin, AstraZeneca, and GlaxoSmithKline Currently Head of Commercial Operations for Gilead Canada Prior to this role as GM UK & Ireland for Amarin, oversaw 15M P&L for anticipated 300M PYS primary asset Built Amarin’s UK & Ireland organisation: in Year 1, set new UK CVD market access launch benchmark and established 14 NHS collaborations Developed and led deployment of AstraZeneca’s Enterprise selling model, launch success framework and strategic planning process; received CEO award for transforming market performance during time as GM of Hong Kong Experience in oncology, cardiometabolic, neurology, CNS, respiratory and gastroenterology areas

Scott Curley has prior
experience in the following industries:
Amarin | Astrazeneca | Astrazeneca Hong Kong | The Hong Kong Association Of The Pharmaceutical Industry | Glaxosmithkline | Smithklinebeecham

Scott Curley has the following professional experience:
Gilead Sciences | Amarin | Astrazeneca | Astrazeneca Hong Kong | The Hong Kong Association Of The Pharmaceutical Industry | Glaxosmithkline | Smithklinebeecham